Skip to main content
Clinical Trials/NCT04414072
NCT04414072
Unknown
Not Applicable

Effect of Bariatric Surgery

Minia University1 site in 1 country150 target enrollmentFebruary 1, 2021
ConditionsMorbid Obesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Morbid Obesity
Sponsor
Minia University
Enrollment
150
Locations
1
Primary Endpoint
hormonal change
Last Updated
5 years ago

Overview

Brief Summary

Background: Many of the beneficial metabolic effects of bariatric surgery have been attributed to altered peptide hormone profiles, especially involving pancreatic and gut peptides.

Objectives: assess the effects of bariatric procedures (sleeve gastrectomy, minigastric bypass and sleeve gastrectomy with loop bipartition) on GIT hormones. Methods: Prospective randomized study which was carried out in the department of General Surgery, Minia University hospital during the period from February 2018 to February 2019. This study included 3 groups subjected to different operations; each group consisted of 50 patients.

Detailed Description

Prospective randomized study which was carried out in the department of General Surgery, Minia University hospital during the period from February 2018 to February 2019. This study included 3 groups subjected to different operations; each group consisted of 50 patients. Age ranging from 20 to 50 years old and body weight ranging from 100 to 200 Kg, and subjected to laparoscopic sleeve gastrectomy, mini gastric bypass and sleeve gastrectomy with loop bipartition. Each patient was thoroughly evaluated by a multidisciplinary team (Nutritionist, Endocrinologist, Psychologist, and Surgeon) using a standardized protocol. Follow up was done after two weeks and after 2 months.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
February 1, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Minia University
Responsible Party
Principal Investigator
Principal Investigator

Amr Abdel Hameed El heny

Assistant professor

Minia University

Eligibility Criteria

Inclusion Criteria

  • All morbid obese patients

Exclusion Criteria

  • GIT diseases

Outcomes

Primary Outcomes

hormonal change

Time Frame: one year

GIT hormones (Ghrelin, secretin, PYY, GLP-1)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
The pleiotropic metabolic effects of bariatric surgery.obesityinsulin sensitivitybariatric surgeryhypothalamusobesitasinsuline gevoeligheidbariatrische chirurgiehypothalamus
NL-OMON29450Academic Medical Center (AMC), Department of Endocrinology and Metabolism P.O. Box 22660 1100 DD Amsterdam The Netherlands +31 (0)20 5669111 20
Recruiting
Not Applicable
Metabolic effects of bariatric surgery (laparoscopic sleeve gastrectomy) on endocrine abnormalitiesObese patients with metabolic abonormalities
JPRN-UMIN000033439Kanazawa University Graduate School of Medical Sciences Department of Endocrinology and Metabolism40
Not yet recruiting
Not Applicable
The pleiotropic metabolic effects of bariatric surgeryobesitas/hypertensie/glucose en lipiden metabolismemetabolic syndrome
NL-OMON33590Academisch Medisch Centrum30
Completed
Phase 4
The influence of having bariatric surgery on the pharmacokinetics, safety and efficacy of the novel non-nucleoside reverse transcriptase inhibitor doravirine (LABRADOR)
NL-OMON51582Afdeling Apotheek1
Active, not recruiting
Phase 1
Exposure to Doravirine in people with HIV undergoing weight loss surgeryHIV plus bariatric surgeryMedDRA version: 20.1Level: LLTClassification code 10068341Term: HIV-1 infectionSystem Organ Class: 100000004862MedDRA version: 21.1Level: LLTClassification code 10068900Term: Bariatric surgerySystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
EUCTR2021-005347-79-NLRadboud University Medical Center8